Carregant...
Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes
BACKGROUND: Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for increased cardiovascular mortality. To assess t...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3662653/ https://ncbi.nlm.nih.gov/pubmed/23717437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0063499 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|